Access cutting-edge breast cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (HER)2- metastatic breast cancer are eligible to a randomized trial. Patients receiving standard first line therapy for metastatic HR+ Breast cancer(BC) (letrozole+palbociclib) are randomly assigned to also receive Stereotactic Body Radiation Therapy(SBRT) to each metastatic lesion.
Sponsor: Weill Medical College of Cornell University
Check if you qualify for this breast cancer clinical trial in New York, NY
If you're searching for breast cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.